354 related articles for article (PubMed ID: 8752251)
1. Relative morbidity of abdominal hysterectomy and myomectomy for management of uterine leiomyomas.
Iverson RE; Chelmow D; Strohbehn K; Waldman L; Evantash EG
Obstet Gynecol; 1996 Sep; 88(3):415-9. PubMed ID: 8752251
[TBL] [Abstract][Full Text] [Related]
2. Uterine fibroid: clinical presentation and relative morbidity of abdominal myomectomy and total abdominal hysterectomy, in a teaching hospital of Karachi, Pakistan.
Mohammed NB; NoorAli R; AnandaKumar C
Singapore Med J; 2002 Jun; 43(6):289-95. PubMed ID: 12380725
[TBL] [Abstract][Full Text] [Related]
3. Morbidity associated with abdominal myomectomy.
LaMorte AI; Lalwani S; Diamond MP
Obstet Gynecol; 1993 Dec; 82(6):897-900. PubMed ID: 8233261
[TBL] [Abstract][Full Text] [Related]
4. Comparability of perioperative morbidity between abdominal myomectomy and hysterectomy for women with uterine leiomyomas.
Sawin SW; Pilevsky ND; Berlin JA; Barnhart KT
Am J Obstet Gynecol; 2000 Dec; 183(6):1448-55. PubMed ID: 11120509
[TBL] [Abstract][Full Text] [Related]
5. Prospective randomised trial comparing gonadotrophin-releasing hormone analogues with triple tourniquets at open myomectomy.
Al-Shabibi N; Chapman L; Madari S; Papadimitriou A; Papalampros P; Magos A
BJOG; 2009 Apr; 116(5):681-7. PubMed ID: 19191779
[TBL] [Abstract][Full Text] [Related]
6. Abdominal myomectomy versus abdominal hysterectomy for symptomatic and big uterine fibroids.
Rouzi AA; Al-Noury AI; Shobokshi AS; Jamal HS; Abduljabbar HS
Saudi Med J; 2001 Nov; 22(11):984-6. PubMed ID: 11744970
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone agonist use before hysterectomy.
Stovall TG; Summit RL; Washburn SA; Ling FW
Am J Obstet Gynecol; 1994 Jun; 170(6):1744-8; discussion 1748-51. PubMed ID: 8203435
[TBL] [Abstract][Full Text] [Related]
8. Uterine size and risk of complications among women undergoing abdominal hysterectomy for leiomyomas.
Hillis SD; Marchbanks PA; Peterson HB
Obstet Gynecol; 1996 Apr; 87(4):539-43. PubMed ID: 8602305
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of perioperative morbidity associated with single and multiple myomectomy.
Kunde K; Cortes E; Seed P; Khalaf Y
J Obstet Gynaecol; 2009 Nov; 29(8):737-41. PubMed ID: 19821669
[TBL] [Abstract][Full Text] [Related]
10. Abdominal myomectomy in women with very large uterine size.
West S; Ruiz R; Parker WH
Fertil Steril; 2006 Jan; 85(1):36-9. PubMed ID: 16412723
[TBL] [Abstract][Full Text] [Related]
11. Explained compared with unexplained fever in postoperative myomectomy and hysterectomy patients.
Rybak EA; Polotsky AJ; Woreta T; Hailpern SM; Bristow RE
Obstet Gynecol; 2008 May; 111(5):1137-42. PubMed ID: 18448746
[TBL] [Abstract][Full Text] [Related]
12. GnRH agonists before surgery for uterine leiomyomas. A review.
Crosignani PG; Vercellini P; Meschìa M; Oldani S; Bramante T
J Reprod Med; 1996 Jun; 41(6):415-21. PubMed ID: 8799917
[TBL] [Abstract][Full Text] [Related]
13. Uterine artery ligation for treatment of pregnant women with uterine leiomyomas who are undergoing cesarean section.
Liu WM; Wang PH; Tang WL; Wang IT; Tzeng CR
Fertil Steril; 2006 Aug; 86(2):423-8. PubMed ID: 16762346
[TBL] [Abstract][Full Text] [Related]
14. A national analysis of the relationship between hospital volume, academic center status, and surgical outcomes for abdominal hysterectomy done for leiomyoma.
Juillard C; Lashoher A; Sewell CA; Uddin S; Griffith JG; Chang DC
J Am Coll Surg; 2009 Apr; 208(4):599-606. PubMed ID: 19476796
[TBL] [Abstract][Full Text] [Related]
15. Vaginal hysterectomy by uterine morcellation: an efficient, non-morbid procedure.
Mazdisnian F; Kurzel RB; Coe S; Bosuk M; Montz F
Obstet Gynecol; 1995 Jul; 86(1):60-4. PubMed ID: 7784024
[TBL] [Abstract][Full Text] [Related]
16. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial.
Muneyyirci-Delale O; Richard-Davis G; Morris T; Armstrong J
Clin Ther; 2007 Aug; 29(8):1682-91. PubMed ID: 17919549
[TBL] [Abstract][Full Text] [Related]
17. Perioperative morbidity associated with abdominal myomectomy compared with total abdominal hysterectomy for uterine fibroids.
Pundir J; Walawalkar R; Seshadri S; Khalaf Y; El-Toukhy T
J Obstet Gynaecol; 2013 Oct; 33(7):655-62. PubMed ID: 24127947
[TBL] [Abstract][Full Text] [Related]
18. Myomectomy after selective preoperative treatment with a gonadotropin releasing hormone analog.
Hutchins FL
J Reprod Med; 1992 Aug; 37(8):699-702. PubMed ID: 1432986
[TBL] [Abstract][Full Text] [Related]
19. Uterine weight as a predictor of morbidity after a benign abdominal and total laparoscopic hysterectomy.
Bonilla DJ; Mains L; Whitaker R; Crawford B; Finan M; Magnus M
J Reprod Med; 2007 Jun; 52(6):490-8. PubMed ID: 17694966
[TBL] [Abstract][Full Text] [Related]
20. Cost and reimbursement for three fibroid treatments: abdominal hysterectomy, abdominal myomectomy, and uterine fibroid embolization.
Goldberg J; Bussard A; McNeil J; Diamond J
Cardiovasc Intervent Radiol; 2007; 30(1):54-8. PubMed ID: 17031734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
